COVID-19 response: Testing and diagnostics

 

Testing and diagnostics

To fight the spread of COVID‑19, the Government of Canada is focussed on building capacity in Canada to develop innovative testing and diagnostic solutions, and purchase essential supplies using existing industrial and innovation programs like the Innovative Solutions Canada (ISC) program and the Pandemic Response Challenge program.

Research and innovation funding to advance diagnostic testing

The Government of Canada is acting quickly to ensure that we are mobilizing our innovation programming and resources to respond to the COVID-19 pandemic.

Learn more about Research and innovation funding to advance diagnostic testing

Working to source diagnostic solutions for COVID-19

Since the onset of COVID-19, the National Research Council of Canada (NRC) has been working with and supporting companies to deliver revolutionary technologies to Canada's public health agencies.

Learn more about Working to source diagnostic solutions for COVID-19

Funding Canadian key enablers to develop diagnostic kits for COVID-19

The Public Health Agency of Canada (PHAC) and the National Research Council of Canada (NRC) collaborated to launch the "Point-of-Care Diagnostic Kit for COVID-19" challenge— seeking a solution from Canadian small and medium-sized businesses.

Learn more about Funding Canadian key enablers to develop diagnostic kits for COVID-19

COVID-19 resources for researchers and clinicians in Canada

In addition to ongoing research projects, the NRC is also a contributor to COVID-19 Resources Canada, a web portal designed to help those working on COVID-19-related research and development initiatives in Canada make connections and locate human resources, expertise, reagents, and equipment.

Learn more about COVID-19 resources for researchers and clinicians in Canada

New made-in-Canada research tool in the fight against COVID-19

The NRC's spike protein reference material is now available for the Canadian research community. This high-quality spike protein antigen can be used for COVID-19 R&D, testing and vaccine development.

Learn more about the new made-in-Canada research tool in the fight against COVID-19

Canadian researchers work together to develop made-in-Canada COVID-19 testing capacity

Through a collaboration with McGill University and support from the NRC Pandemic Response Challenge program, NRC scientists are working together to be part of the testing capacity.

Learn more about how Canadian researchers work together to develop made-in-Canada COVID-19 testing capacity